NLA – National Lipid Association and Elsevier Announce Publishing Partnership Plan
New Journal of Clinical Lipidology will be launched in March 2007
New York, 2 November, 2006 — Elsevier, world-leading scientific, technical and medical publisher, is pleased to announce its new partnership with the NLA – National Lipid Association, the leading society for medical doctors and other health care professionals who work to reduce the incidence of morbidity and mortality from dyslipidemia and associated disorders of lipid metabolism.
In March 2007, the Association and Elsevier will commence publication of the Journal of Clinical Lipidology as the official publication of the Association. Dr. W. Virgil Brown, who is Charles Howard Candler Professor of Internal Medicine at Emory University School of Medicine, and Chief of Medicine at the Atlanta VAMC, will serve as Founding Editor-in-Chief of the new journal.
Journal of Clinical Lipidology will present scientific and clinical research from every field involved in lipids and clinical lipidology. The specialty of "lipidology," a multidisciplinary branch of medicine focusing on lipid and lipoprotein metabolism and their associated disorders, is still in its infancy and continues to evolve with the field of medicine as a whole. The field is growing rapidly in response to demographic trends that place an increasing number of Americans at risk for coronary heart disease (CHD) and epidemic levels of obesity concurrent with a surge in new cases of diabetes mellitus.
In addition to presenting peer-reviewed research, reviews, and editorials, the new journal will occasionally publish the Association’s consensus reports, dyslipidemia and cholesterol reduction guidelines, and, among other official reports, the plenary lecture from the National Lipid Association’s scientific sessions.
According to Dr. Brown, "there has been no journal to date that serves the entire clinical lipidology field, targeted specifically at practitioners, clinical academic researchers, and trainees, all of whom are integral components of the diagnosis and treatment of patients with lipid disorders and cardiovascular disease, this journal will incisively address this challenge.”
Beginning in March 2007, the full-text of each issue of Journal of Clinical Lipidology will be available online to National Lipid Association members and individual subscribers through its customized website, as well as through Elsevier's online subscription service, ScienceDirect for institutional subscriptions.
"The leadership of the National Lipid Association are convinced that it is essential for our organization to establish its own forum to address the needs and concerns of the international lipidology community," said James M. McKenney, PharmD, President of the National Lipid Association. "Our new partnership with Elsevier, and the upcoming launch of Journal of Clinical Lipidology, represents a major step forward in meeting the Association’s goal of international leadership in science, education, and advocacy for the diagnosis and treatment of disease in the area of clinical lipidology.
"Our new journal will cover the gamut of topics in clinical lipidology today, addressing the common challenges of physicians, nurses, dieticians and pharmacists who help manage patients with lipid disorders and cardiovascular disease.” “Our mission”, added Dr. Brown, “is to help reduce deaths related to high, bad LDL cholesterol and further, the journal’s scope will be to enhance the practice of lipid management in clinical medicine and to reduce the morbidity and mortality associated with atherosclerotic disease. Ultimately, our goal will be to educate, advocate, and perhaps, at times, even to pontificate.”
For information on subscribing or submitting manuscripts to Journal of Clinical Lipidology visit www.elsevierhealth.com.
###About the National Lipid Association
The National Lipid Association (NLA) is a non-profit membership association that serves physicians, nurses, pharmacists and dieticians who help manage patients with lipid disorders and cardiovascular disease. The NLA represents more than 2,000 members in the United States and provides continuing medical education for physicians and other healthcare professionals to advance professional development and attain certification in clinical lipidology. The NLA's public health mission is to help reduce deaths related to high cholesterol.
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and 25,000 book titles, including major reference works from Mosby and Saunders. Elsevier’s online solutions include ScienceDirect, Scopus, SciVal, Reaxys, ClinicalKey and Mosby’s Suite, which enhance the productivity of science and health professionals, helping research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
Journals Strategic Marketing
+1 (215) 239-3360